K-Vani
C2i Genomics and Karkinos Healthcare Partner to Bring AI-Powered Cancer Detection and Monitoring to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India… Read More
- All
- Breast Cancer
- Karkinos in Press & Media
- Newsroom
- All
- Breast Cancer
- Karkinos in Press & Media
- Newsroom
Breast Cancer Surgery Options and the Role of the Tumour Board
This blog explores what a patient and the family members need to know about surgical options, the factors driving the surgeon’s recommendation, and how a … Read More
Genetic Testing & Counselling: Life-Saving Benefits Explained
This blog explores how genetic testing uncovers hidden health risks inside your DNA to help protect your family. It also shows how genetic counsellors guide … Read More
Reliance-owned Karkinos Healthcare crosses one lakh HPV DNA tests, strengthening India’s cervical cancer prevention efforts
Mumbai, June 24, 2026: Karkinos Healthcare, a 100% step-down subsidiary of Reliance Industries
Ltd., has completed HPV DNA screening for over one lakh women across … Read More
Beyond BRCA: The other genes involved in breast cancer
This blog focuses on understanding genes beyond BRCA1 and BRCA2, which is essential for Indian women because the biological and genetic landscape of breast cancer … Read More
How Do BRCA1 and BRCA2 Mutations Cause Breast Cancer?
A mutation in the BRCA gene, specifically BRCA1 or BRCA2, significantly increases a woman’s lifetime risk of developing breast cancer. Read this blog to know … Read More
HER2 and its strong link to aggressive breast cancer
HER2 is a molecule that significantly influences the behaviour of certain types of breast cancer. Understanding HER2 helps explain why some tumours grow rapidly and … Read More
